HemaSphere (Jun 2022)
S252: M2-POLARIZED MACROPHAGES CONTROL LEUKEMIC STEM CELL FATE BY PROMOTING METABOLIC REPROGRAMMING
- I. Weinhäuser,
- D. A. Pereira-Martins,
- J. R. Hilberink,
- L. Y. Almeida,
- D. R. A. Silveira,
- L. Quek,
- S. M Hogeling,
- J. M. Mota,
- E. Ammatuna,
- A. R. Lucena-Araujo,
- G. A. Huls,
- E. M. Rego,
- J. J. Schuringa
Affiliations
- I. Weinhäuser
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- D. A. Pereira-Martins
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- J. R. Hilberink
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- L. Y. Almeida
- 2 Center for Cell Based Therapy, University of Sao Paulo
- D. R. A. Silveira
- 4 Myeloid Leukaemia Genomics and Biology Group, Kings College London, London, United Kingdom
- L. Quek
- 4 Myeloid Leukaemia Genomics and Biology Group, Kings College London, London, United Kingdom
- S. M Hogeling
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- J. M. Mota
- 5 Medical Oncology Service, Sao Paulo State Cancer Institute, Sao Paulo
- E. Ammatuna
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- A. R. Lucena-Araujo
- 6 Department of Genetics, Federal University of Pernambuco, Recife
- G. A. Huls
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- E. M. Rego
- 7 Center for Cell Based Therapy, University of Sao Paulo, Sao Paulo, Brazil
- J. J. Schuringa
- 1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000843900.20659.ec
- Journal volume & issue
-
Vol. 6
pp. 153 – 154
Abstract
No abstracts available.